Journals / Eurasian Journal of Pulmonology / 2018 / Cilt: 20 - Sayı: 3

Rarely occurrance of two diffuse idiopathic neuroendocrine cell hyperplasia cases

Pages
167–170
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We wanted to emphasize the importance of DIPNECH which is a rare clinical entity causing chronic respiratory symptoms which should be considered in differential diagnosis of multiple pulmonary nodules.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is a rare disease which needs a long time for diagnosis and usually defined by case reports and small series.
📊
Key Findings & Data:We reported two cases, one with 67 and the other with 66‑years‑old, both of them were female.
💡
Conclusion & Impact:We wanted to emphasize the importance of DIPNECH which is a rare clinical entity causing chronic respiratory symptoms which should be considered in differential diagnosis of multiple pulmonary nodules.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is a rare disease which needs a long time for diagnosis and usually defined by case reports and small series. We reported two cases, one with 67 and the other with 66‑years‑old, both of them were female. They presented with long‑lasting complaints of cough and shortness of breath. Computed tomography of patients showed multiple nodules on the basis of lungs, and additionally, mosaic perfusion was seen in the first case. Tissue samples were taken with video‑assisted thoracic surgery, and the patients were diagnosed with DIPNECH by immunohistochemical examination. We wanted to emphasize the importance of DIPNECH which is a rare clinical entity causing chronic respiratory symptoms which should be considered in differential diagnosis of multiple pulmonary nodules.

🔖

Cite This Article

Umudum, H., Han, S., Ogan, N., Baha, A., Akpinar, E. E. (2022). Rarely occurrance of two diffuse idiopathic neuroendocrine cell hyperplasia cases. Eurasian Journal of Pulmonology, Cilt: 20 - Sayı: 3, 167–170. https://ajindex.com/articles/509675

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Benson RE, Rosado‑de‑Christenson ML, Martínez‑Jiménez S, Kunin JR, Pettavel PP. Spectrum of pulmonary neuroendocrine proliferations and neoplasms. Radiographics 2013;33:1631‑49
  2. Carr LL, Chung JH, Duarte Achcar R, Lesic Z, Rho JY, Yagihashi K, et al. The clinical course of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia. Chest 2015;147:415‑22
  3. Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JH, Beasley MB, et al. The 2015 World Health Organization classification of lung tumors: Impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol 2015;10:1243‑60
  4. Rossi G, Cavazza A, Spagnolo P, Sverzellati N, Longo L, Jukna A, et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia syndrome. Eur Respir J 2016;47:1829‑41
  5. Chassagnon G, Favelle O, Marchand‑Adam S, De Muret A, Revel MP. DIPNECH: When to suggest this diagnosis on CT. Clin Radiol 2015;70:317‑2